FDA Investigator Anthony F Lorenzo
Anthony F Lorenzo has inspections in 7 countries as of 19 Sep 2023. Anthony F Lorenzo has collaborated with a combinined 3525 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Singapore,
Israel,
Switzerland,
Belgium,
Austria,
Sweden
Co-Investigator(s):
Ademola O Daramola,
Alan L Truong,
Alanna Lmussawwir Bias,
Alice S Tsao,
Amy S Graf,
Andrew A Leboeuf,
Andrey Sarafanov, PhD,
Anissa M Cheung,
Ann Marie Montemurro,
Annet R Rajan,
Anthony W Lee,
Art O Czabaniuk,
Azza Talaat,
Bei Y He,
Brian D Nicholson,
Brian R Yaun,
Brooke K Higgins,
Brooke K Secman,
Brooke K Seeman,
Bruce H Mccullough,
Burnell M Henry,
Candice C Mandera,
Candice J Cortes,
Carole L Jones,
CDR Cecily Jones,
CDR Ileana Barreto Pettit,
CDR Jeremy L Wally, PhD,
CDR Sean T Creighton,
Chad E Schmear,
Christian D Lynch (CDL),
Christopher D Leach,
Cynthia Jim, CSO,
Daniel J Brown,
Darrell E Luedtke,
David A Oluwo,
David Doleski,
David J Gasparovich,
David Perkins,
Deborah M Trout,
Debra I Love,
Denise L Burosh,
Derek S Smith, PhD,
Diane T Bargo,
Diane T O'bien,
Diane T O'brien,
Don H Bark, PhD,
Douglas A Campbell,
Dr. Gang Wang, PhD,
Eileen A Liu,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Ephrem Hunde, PhD,
Eric M Mueller, PharmD,
Eric S Pittman,
Felice D'agnillo, PhD,
Gene D Arcy,
Gerald B Seaborn, Jr,
Gregory R Dill,
Haruhiko Murata,
Hongna Wang,
J David Doleski,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James R Evans,
James W Leonette,
James W Plucinski,
Janet A Rajan,
Jean Lhu Primmer,
Jeanne M Morris,
Jeffrey D Meng,
Jennifer L Reed,
Jennifer L Schmidt,
Jesse A Vazquez,
Jessica Hankins, PhD,
Jessica L Pressley,
Jie He,
Joan A Loreng,
Jonathan W Chapman,
Joohi Castelvetere,
Jose Acruz Gonzalez,
Jose R Hernandez,
Joseph A Piechocki,
Joseph T Madak,
Joshua P Wireman,
Justin A Boyd,
Karen Emasley Joseph,
Kathleen M Jordan,
Kelly L Anderson,
Kenneth Nieves,
Kyran R Gibson,
Larry K Austin,
Laura Fontan, MS,
Laureen F Kononen,
Lauren M Lilly, PhD,
Lawrence J Stringer,
LCDR Debra Emerson,
Lequita M Mayhew,
Lindsey Brown, PhD,
Lorelei S Jarrell,
Lori S Lawless,
Lu Deng,
Maksim A Levenchuk,
Malgorzata G Norton,
Marcus A Ray,
Margaret Torres Vazquez,
Marion Michaelis,
Mark E Frank,
Marlene G Swider,
Mary P Padgett,
Melissa J Garcia,
Merideth K Rose,
Miah I Schneider,
Michael C Kennedy, PhD,
Michael J Vardon,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nancy Kirschbaum, PhD,
Nawab A Siddiqui,
Nebil A Oumer,
Nicholas A Violand,
Nicholas Z Lu,
Nicole K Trudel,
Norman Wong,
Olga Simakova,
Omotunde O Osunsanmi,
Pankaj H Amin,
Paola S Barnett,
Parul M Patel,
Parul Patel Sullivan,
Patricia A Mcilroy,
Patsy J Domingo,
Paul A Bonneau,
Paul D Keller,
Paul W Keller,
Penny H Mccarver,
Phung Thien Nguyen,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Priscilla M Pastrana,
Qin Xu,
Quyen T Tran,
Rachel C Harrington,
Rachel T Evans,
Randa Melhem, PhD,
Rebecca E Dombrowski,
Rebecca K Olin,
Regina Gibson Melton,
Robert D Tollefsen,
Robert J Maffei,
Robert J Martin,
Roberta W Cunningham,
Robin Levis, PhD,
Roger F Zabinski,
Rose M Ashley,
Russell K Riley,
Salwa K Poole,
Sanket N Patel,
Santos E Camara,
Sarah E Rhoades,
Sarah M Meng,
Sarah M Napier,
Scott T Ballard,
Sena G Dissmeyer,
Shirshendu K Deb, PhD,
Sidney B Priesmeyer,
Simone E Pitts,
Stephen D Eich,
Steven A Rubin,
Steven J Thurber,
Steven P Donald,
Susan M Jackson,
Susan P Bruederle,
Swati Verma,
Tamara Brey,
Temar Q Williams,
Thai D Truong,
That Q Dang,
Thomas R Withers,
Tina M Pawlowski,
Tina S Roecklein,
Todd M Stankewicz,
Tonia F Bernard,
Toyin B Oladimeji,
Walter Fava,
Walter L Fava,
William A Warnick,
William H Linkroum,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Yiping Jia,
Yonggang Wang, PhD,
Zachary A Bogorad,
Ze Peng,
Zhongren Wu,
Zuben E Sauna, PhD
Anthony F Lorenzo's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2012 | FDA 483 | Octapharma AB - Form 483, 2012-07-30 |
| February, 2014 | FDA 483 | Seqirus Inc - Form 483, 2014-02-12 |
| July, 2016 | FDA 483 | Octapharma AB - Form 483, 2016-07-14 |
| August, 2010 | FDA 483 | Cangene BioPharma, LLC - Form 483, 2010-08-27 |
| September, 2010 | FDA 483 | CAF-DAF scrl - Form 483, 2010-09-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more